[Spinal deformity in neurofibromatosis type 1].

Area of Science:

• Orthopedics
• Genetics
• Pediatric Medicine

Background:

• Spinal deformity affects up to 60% of individuals with neurofibromatosis type 1 (NF1).
• NF1-associated spinal deformities are classified as non-dystrophic or dystrophic.
• This classification is critical due to distinct therapeutic approaches for each type.

Purpose of the Study:

• To highlight the importance of differentiating between non-dystrophic and dystrophic spinal deformities in NF1.
• To outline the management strategies for each type of spinal deformity in NF1.
• To emphasize the clinical implications of spinal dysplasia in NF1.

Main Methods:

• Review of clinical characteristics of NF1-associated spinal deformities.
• Comparison of treatment strategies for non-dystrophic and dystrophic spinal deformities.
• Analysis of the progression patterns and outcomes for each type.

Main Results:

• Non-dystrophic spinal deformities in NF1 can be managed similarly to idiopathic scoliosis.
• Spinal dysplasia, termed 'modulation,' can alter the progression of non-dystrophic deformities, mimicking dystrophic types.
• Dystrophic spinal deformities in NF1 exhibit rapid progression, resist conservative treatment, and necessitate early surgical intervention.

Conclusions:

• Accurate diagnosis of non-dystrophic versus dystrophic spinal deformity in NF1 is essential for effective treatment.
• Understanding spinal dysplasia and disease peculiarities is key to managing challenging NF1 spinal cases.
• Early surgical intervention is vital for dystrophic NF1 spinal deformities to prevent severe outcomes.